Shanghai Haishun New Pharmaceutical Packaging Co Ltd
SZSE:300501
Income Statement
Earnings Waterfall
Shanghai Haishun New Pharmaceutical Packaging Co Ltd
Revenue
|
1.1B
CNY
|
Cost of Revenue
|
-762.6m
CNY
|
Gross Profit
|
294m
CNY
|
Operating Expenses
|
-164m
CNY
|
Operating Income
|
130m
CNY
|
Other Expenses
|
-19.8m
CNY
|
Net Income
|
110.2m
CNY
|
Income Statement
Shanghai Haishun New Pharmaceutical Packaging Co Ltd
Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||||||||
Revenue |
294
N/A
|
290
-1%
|
282
-3%
|
284
+1%
|
301
+6%
|
319
+6%
|
337
+6%
|
365
+8%
|
376
+3%
|
405
+8%
|
436
+8%
|
463
+6%
|
507
+9%
|
561
+11%
|
572
+2%
|
608
+6%
|
621
+2%
|
613
-1%
|
643
+5%
|
658
+2%
|
714
+9%
|
782
+10%
|
816
+4%
|
841
+3%
|
857
+2%
|
865
+1%
|
908
+5%
|
950
+5%
|
1 013
+7%
|
1 041
+3%
|
1 060
+2%
|
1 057
0%
|
|
Gross Profit | |||||||||||||||||||||||||||||||||
Cost of Revenue |
(186)
|
(183)
|
(175)
|
(174)
|
(185)
|
(198)
|
(212)
|
(235)
|
(236)
|
(260)
|
(284)
|
(307)
|
(342)
|
(386)
|
(397)
|
(419)
|
(429)
|
(427)
|
(440)
|
(448)
|
(472)
|
(520)
|
(562)
|
(591)
|
(612)
|
(633)
|
(661)
|
(696)
|
(745)
|
(766)
|
(777)
|
(763)
|
|
Gross Profit |
108
N/A
|
106
-1%
|
107
+1%
|
110
+3%
|
116
+5%
|
121
+4%
|
125
+3%
|
130
+4%
|
140
+8%
|
145
+4%
|
153
+5%
|
157
+3%
|
165
+5%
|
175
+6%
|
174
0%
|
188
+8%
|
193
+2%
|
186
-3%
|
203
+9%
|
210
+3%
|
242
+15%
|
262
+9%
|
255
-3%
|
251
-2%
|
245
-2%
|
232
-5%
|
247
+6%
|
253
+3%
|
268
+6%
|
275
+3%
|
283
+3%
|
294
+4%
|
|
Operating Income | |||||||||||||||||||||||||||||||||
Operating Expenses |
(45)
|
(41)
|
(45)
|
(45)
|
(50)
|
(54)
|
(56)
|
(62)
|
(70)
|
(71)
|
(81)
|
(85)
|
(95)
|
(105)
|
(113)
|
(121)
|
(129)
|
(124)
|
(118)
|
(107)
|
(129)
|
(128)
|
(129)
|
(138)
|
(138)
|
(133)
|
(145)
|
(145)
|
(155)
|
(149)
|
(156)
|
(164)
|
|
Selling, General & Administrative |
(26)
|
(41)
|
(44)
|
(44)
|
(32)
|
(54)
|
(48)
|
(49)
|
(53)
|
(70)
|
(70)
|
(75)
|
(69)
|
(78)
|
(93)
|
(102)
|
(94)
|
(98)
|
(98)
|
(95)
|
(96)
|
(104)
|
(101)
|
(103)
|
(98)
|
(102)
|
(110)
|
(109)
|
(109)
|
(109)
|
(114)
|
(119)
|
|
Research & Development |
(17)
|
0
|
0
|
0
|
(16)
|
0
|
0
|
(4)
|
(17)
|
0
|
0
|
(2)
|
(22)
|
(10)
|
(20)
|
(22)
|
(26)
|
(28)
|
(24)
|
(24)
|
(23)
|
(26)
|
(28)
|
(30)
|
(32)
|
(34)
|
(41)
|
(43)
|
(42)
|
(45)
|
(45)
|
(48)
|
|
Depreciation & Amortization |
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
(12)
|
0
|
0
|
0
|
(12)
|
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
(12)
|
0
|
0
|
0
|
|
Other Operating Expenses |
(0)
|
0
|
0
|
(1)
|
(0)
|
0
|
(9)
|
(9)
|
2
|
0
|
(10)
|
(8)
|
4
|
(17)
|
0
|
2
|
2
|
2
|
4
|
12
|
2
|
1
|
1
|
(6)
|
3
|
4
|
5
|
7
|
9
|
6
|
4
|
3
|
|
Operating Income |
63
N/A
|
65
+3%
|
63
-4%
|
66
+5%
|
66
+1%
|
67
+1%
|
69
+3%
|
68
-1%
|
70
+4%
|
74
+5%
|
72
-2%
|
72
-1%
|
70
-2%
|
70
+1%
|
61
-13%
|
68
+10%
|
63
-6%
|
62
-1%
|
85
+37%
|
102
+20%
|
113
+10%
|
134
+19%
|
126
-6%
|
112
-11%
|
106
-5%
|
100
-6%
|
101
+2%
|
108
+7%
|
113
+5%
|
126
+11%
|
128
+1%
|
130
+2%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||||||||
Interest Income Expense |
3
|
3
|
3
|
3
|
7
|
8
|
8
|
8
|
6
|
4
|
7
|
9
|
8
|
8
|
5
|
6
|
11
|
8
|
12
|
11
|
7
|
9
|
7
|
5
|
12
|
10
|
13
|
16
|
10
|
(0)
|
(13)
|
8
|
|
Non-Reccuring Items |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
(2)
|
0
|
0
|
(0)
|
(1)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(1)
|
0
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
2
|
1
|
1
|
3
|
1
|
2
|
3
|
3
|
1
|
(0)
|
(1)
|
(1)
|
1
|
0
|
5
|
5
|
(0)
|
(1)
|
(7)
|
(7)
|
(1)
|
(1)
|
(1)
|
(1)
|
1
|
(0)
|
(0)
|
0
|
1
|
0
|
0
|
0
|
|
Pre-Tax Income |
69
N/A
|
68
0%
|
67
-2%
|
71
+6%
|
74
+4%
|
77
+4%
|
80
+4%
|
78
-3%
|
77
-1%
|
77
+1%
|
78
+1%
|
80
+3%
|
77
-4%
|
79
+2%
|
71
-10%
|
77
+9%
|
73
-5%
|
70
-5%
|
91
+31%
|
107
+17%
|
119
+11%
|
142
+19%
|
133
-7%
|
116
-12%
|
117
+1%
|
109
-7%
|
114
+5%
|
124
+8%
|
123
-1%
|
126
+2%
|
115
-9%
|
138
+20%
|
|
Net Income | |||||||||||||||||||||||||||||||||
Tax Provision |
(10)
|
(9)
|
(8)
|
(9)
|
(9)
|
(10)
|
(14)
|
(13)
|
(11)
|
(11)
|
(10)
|
(11)
|
(13)
|
(13)
|
(12)
|
(12)
|
(7)
|
(6)
|
(9)
|
(13)
|
(13)
|
(17)
|
(15)
|
(10)
|
(8)
|
(7)
|
(7)
|
(8)
|
(13)
|
(13)
|
(15)
|
(18)
|
|
Income from Continuing Operations |
59
|
59
|
59
|
62
|
65
|
66
|
66
|
65
|
66
|
66
|
68
|
70
|
64
|
66
|
59
|
65
|
66
|
64
|
82
|
94
|
105
|
125
|
118
|
106
|
109
|
102
|
107
|
116
|
110
|
113
|
100
|
120
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
1
|
2
|
2
|
2
|
1
|
1
|
0
|
(0)
|
(1)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(5)
|
(6)
|
(7)
|
(7)
|
(9)
|
(10)
|
(10)
|
|
Net Income (Common) |
59
N/A
|
59
+0%
|
59
+1%
|
62
+5%
|
65
+4%
|
66
+2%
|
66
-1%
|
64
-2%
|
66
+2%
|
67
+1%
|
69
+3%
|
70
+3%
|
66
-6%
|
68
+2%
|
61
-9%
|
66
+8%
|
67
+1%
|
64
-5%
|
82
+28%
|
94
+14%
|
103
+10%
|
122
+19%
|
114
-6%
|
103
-10%
|
105
+1%
|
97
-8%
|
101
+5%
|
109
+8%
|
102
-6%
|
104
+1%
|
90
-13%
|
110
+22%
|
|
EPS (Diluted) |
0.52
N/A
|
0.38
-27%
|
0.39
+3%
|
0.41
+5%
|
0.67
+63%
|
0.65
-3%
|
0.32
-51%
|
0.42
+31%
|
0.43
+2%
|
0.44
+2%
|
0.44
N/A
|
0.46
+5%
|
0.44
-4%
|
0.44
N/A
|
0.4
-9%
|
0.43
+7%
|
0.43
N/A
|
0.4
-7%
|
0.54
+35%
|
0.61
+13%
|
0.66
+8%
|
0.78
+18%
|
0.73
-6%
|
0.53
-27%
|
0.64
+21%
|
0.49
-23%
|
0.52
+6%
|
0.57
+10%
|
0.53
-7%
|
0.54
+2%
|
0.47
-13%
|
0.57
+21%
|